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Abstract
The activity-induced transcription factor ΔFosB has been implicated in Alzheimer’s disease
(AD) as a critical regulator of hippocampal function and cognition downstream of seizures
and network hyperexcitability. With its long half-life (> 1 week), ΔFosB is well-poised to modulate hippocampal gene expression over extended periods of time, enabling effects to persist even during seizure-free periods. However, the transcriptional mechanisms by which
ΔFosB regulates hippocampal function are poorly understood due to lack of identified hippocampal gene targets. To identify putative ΔFosB gene targets, we employed high-throughput sequencing of genomic DNA bound to ΔFosB after chromatin immunoprecipitation
(ChIP-sequencing). We compared ChIP-sequencing results from hippocampi of transgenic
mice expressing mutant human amyloid precursor protein (APP) and nontransgenic (NTG)
wild-type littermates. Surprisingly, only 52 ΔFosB gene targets were shared between NTG
and APP mice; the vast majority of targets were unique to one genotype or the other. We
also found a functional shift in the repertoire of ΔFosB gene targets between NTG and APP
mice. A large number of targets in NTG mice are involved in neurodevelopment and/or cell
morphogenesis, whereas in APP mice there is an enrichment of targets involved in regulation of membrane potential and neuronal excitability. RNA-sequencing and quantitative
PCR experiments confirmed that expression of putative ΔFosB gene targets were altered in
the hippocampus of APP mice. This study provides key insights into functional domains regulated by ΔFosB in the hippocampus, emphasizing remarkably different programs of gene
regulation under physiological and pathological conditions.
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Introduction
The leucine zipper transcription factor ΔFosB belongs to the immediate early gene (IEG) family of proteins that are induced by neuronal activation to enact various activity-dependent programs in the cell [1]. ΔFosB is the truncated splice variant of FosB; this truncation is significant
as it removes two C-terminal degron domains, making ΔFosB particularly resistant to proteasomal degradation [2]. Therefore, the half-life of ΔFosB is unusually long (~8 days in vivo),
allowing it to modulate neuronal gene expression over prolonged periods of time [3]. The
chronic and persistent nature of ΔFosB’s effect on neuronal and network function has been
well-characterized in the nucleus accumbens, where it modifies addictive behavior following
repetitive exposure to drugs of abuse [4]. Such studies also showed that ΔFosB epigenetically
enhances or silences transcription of various target genes via recruitment of histone-modifying
enzymes such as p300/CBP or HDAC1 to target gene promoters, respectively [5–7].
ΔFosB expression is also increased in the hippocampus after seizure activity in various models of epilepsy where it has been used as a marker of activity [8–14]. Recently, we discovered
that seizures and epileptiform activity also robustly increased ΔFosB expression in the hippocampus of a transgenic mouse model of Alzheimer’s disease (AD) expressing mutant human
amyloid precursor protein (APP, line J20) as well as in pharmacological models of epilepsy [15,
16]. We found similar increases in ΔFosB expression in the hippocampus of AD patients and in
patients with temporal lobe epilepsy [16]. The increase in ΔFosB expression had a significant
impact on hippocampal function in APP mice, by suppressing expression of two genes essential
for neuronal plasticity, Fos and Calb1, and by impairing hippocampus-dependent spatial memory [15, 16]. Treatment of APP mice with the antiepileptic drug levetiracetam reduced both epileptiform activity and ΔFosB expression, with concomitant improvement in cognition. Given
evidence that seizures and epileptiform activity contribute to cognitive decline in AD [17, 18],
the finding that seizures in AD increase hippocampal ΔFosB expression thus provides a mechanism to explain how even intermittent ictal events can cause persistent cognitive deficits.
However, considering the magnitude of ΔFosB upregulation following seizures, this unique
transcription factor likely regulates many other aspects of hippocampal function in addition to
neuronal plasticity. Consistent with this, viral overexpression of ΔFosB in area CA1 of the hippocampus altered dendritic spine morphology and modified behavior in several hippocampus-dependent tasks [19]. Therefore, to achieve a broader understanding of ΔFosB’s role in the
hippocampus, we comprehensively profiled putative ΔFosB gene targets via high-throughput
sequencing of genomic DNA bound by ΔFosB, enriched via chromatin immunoprecipitation
(i.e. ΔFosB ChIP-sequencing, or ChIP-seq). Gene target profiles were generated using hippocampi obtained from both APP mice and nontransgenic (NTG) wild-type littermates from the
same line of J20 APP mice used in our original studies [15, 16].
The results of this ChIP-seq analysis demonstrated that the repertoire of ΔFosB gene targets
in the hippocampus covers broad functional domains, from cell-cell adhesion to regulation of
ion channels and transporters. The ChIP-seq data also highlighted a diversification of ΔFosB’s
functions under pathologic conditions, as both the number of gene targets and the number of
over-represented gene ontology (GO) categories increased in APP versus NTG mice. Indeed, a
comparison of major GO categories in NTG and APP mice revealed a significant functional
shift in ΔFosB gene targets. In NTG mice, a large proportion of gene targets function in neurodevelopment and maintenance of neural circuitry. In contrast, targets involved in the regulation of membrane potential and neuronal excitability were highly represented in APP mice.
Using RNA-seq and qPCR, we demonstrated that differential binding of ΔFosB to various
gene targets in NTG and APP mice corresponds with downstream changes in mRNA expression. Together, our results highlight the diverse and complex programs of gene regulation that
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are coordinated by ΔFosB in the hippocampus of APP mice and potentially other animal models with recurrent seizures.

Materials and methods
Animals
Heterozygous APP transgenic mice expressing human APP carrying the Swedish (K670N,
M671L) and Indiana (V717F) familial AD mutations (hAPP770 numbering) driven by the
platelet-derived growth factor (PDGF) β chain promoter (Line J20) [20] were used in this study.
The line was crossed for >10 generations onto a C57BL/6 background, and heterozygosity is
maintained by breeding with wild-type C57BL/6 mice from The Jackson Laboratory. Male and
female mice from this line that were 4 months of age were used for experiments. At this age,
APP mice exhibit both recurrent seizures and cognitive deficits, but no plaque deposits [15, 20].
Age- and sex-matched nontransgenic (NTG) wild-type animals from the same line were used as
controls. Mice were anesthetized with isoflurane and then transcardially perfused with saline.
Brains were removed and hemisected: one hemibrain was post-fixed in 4% paraformaldehyde
in phosphate-buffered saline for 48 hours at 4 degrees C, and the other hemibrain was flash- frozen on dry ice for biochemical experiments. All experiments involving animals were carried out
in strict accordance with recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health, and followed protocol AN-6943 approved by the
Institutional Animal Care and Use Committee of Baylor College of Medicine.

Chromatin immunoprecipitation (ChIP)
We previously demonstrated that in the same line of APP mice used in this study, the frequency of seizures directly corresponds to the magnitude of ΔFosB expression in the dentate
gyrus, and that treatment with the antiepileptic drug levetiracetam reduces epileptiform activity and normalizes ΔFosB expression [15, 16]. Notably, both epileptiform activity and the corresponding expression of ΔFosB is variable in this line of APP mice, as well as in other APP
mice, and correlates inversely with cognitive function [15, 16]. Since the goal of the present
experiments was to identify the gene targets bound by ΔFosB in APP mice with seizures and
high levels of ΔFosB expression, we first confirmed that the APP mice used for ChIP-sequencing exhibit high ΔFosB expression. We did so by performing ΔFosB immunostaining on one
hemibrain of each mouse in a group of 4-month old sex-matched APP and NTG mice (NTG,
n = 15, 7 female and 8 male; APP, n = 15, 11 female and 4 male). ChIP was performed on the
hippocampus of the opposite hemibrain from two female APP mice with high levels of ΔFosB
expression and two female NTG controls, as previously described [15, 16]. Sonicated chromatin was processed using the Magna ChIP A Kit (Millipore). Antibodies were used at 2 μg/reaction for ChIP, and included rabbit anti-ΔFosB (Cell Signaling D3S8R) and normal rabbit IgG
(Millipore 12–370). Prior to the addition of antibody, 2% of the sheared chromatin was set
aside as input. Quality of ChIP DNA was assessed via qPCR analysis of Calb1 gene pulldown
by ΔFosB, which confirmed that ΔFosB bound Calb1 in our ChIP samples, and that binding
was increased in the two APP mice selected for ChIP-seq relative to NTG controls, as published previously [16]. Primers for Calb1 gene amplification are as follows: 5'-TTCAAATAC
TCAACTGCCTCG-3' (forward); 5'-GGAGGCTTTCACTCCTGAATGT-3' (reverse).

ChIP-sequencing (ChIP-seq) and peak mapping
ChIP-seq library preparation (NEBNext, New England Biolabs), sequencing, and peak calling was
performed by the University of Pennsylvania Next-Generation Sequencing Core. Briefly, ΔFosB
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ChIP-seq enrichment data were obtained from Illumina hiSeq 2500 sequencing (single-read,
50-bp read depth). Statistically significant ChIP-seq peaks were identified by within-mouse comparison of regional read enrichment between ΔFosB ChIP and no-antibody input samples (negative control), mapped onto the mm9 genome. A Fisher’s exact test with a Benjamini-Hochberg
correction [21] calculated enrichment of ChIP signal (relative to input) for each identified peak,
scoring by enrichment ratio and reporting the statistical significance of peaks with p<0.05. The
gene closest to each statistically significantly enriched peak was then reported for each mouse, providing a list of putative genes bound by ΔFosB in both NTG and APP mice. Individual gene lists
from animals of the same genotype were pooled to generate three lists: one for each genotype and
a list containing genes with significantly enriched peaks shared by both genotypes.

Gene ontology (GO) analysis
Cytoscape 3.4.0 [22] was used in conjunction with the plug-in ClueGO 2.2.6 [23] to perform
GO analysis. GO enrichment was determined for each genotype’s gene list using a two-sided
hypergeometric test with a Benjamini-Hochberg correction, showing Biological Process GO
terms significantly (FDR<0.05, GO updated 10/16/2016) enriched with genes from ChIP-seqderived lists. In addition to calculating GO term enrichment, ClueGO was used to create functionally grouped annotation networks, showing significantly enriched GO terms as interconnected nodes with weighted lines (edges) that indicate the proportion of genes shared by
different nodes. The color-coded clusters depicted for each genotype analysis are those containing the most highly significantly enriched GO terms from Fig 1, simplified to remove
redundancy. Additional parameters were set to depict and highlight key aspects of each GO
network. GO level minima were set to exclude overly broad GO terms from GO levels 1–2 and
GO level maxima were set to return the maximal number of significant GO terms per gene list
regardless of their level of detail. Kappa values were set iteratively to generate clusters of comparable inclusivity/size between the gene lists and other parameters were set to maximize
information and visual clarity. Parameters for NTG network construction: GO level range = 3–16, kappa = 0.49, minimum number of genes included in term = 2, minimum percentage of
genes included in term = 2%, GO term fusion/grouping = on. For APP network: GO level
range = 3–15, kappa = 0.57, minimum number of genes included in term = 2, minimum percentage of genes included in term = 1.2%, GO term fusion/grouping = on.

RNA extraction and qRT-PCR
RNA extraction was performed using adapted instructions from the Qiagen RNeasy Mini kit
(74106). For these experiments, hippocampi were isolated from 2–3 month old mice (NTG,
n = 17, 9 male and 8 female; APP, n = 13, 8 male and 5 female). Hippocampi were then submerged in RLT/β-mercaptoethanol buffer, minced with small scissors, and homogenized by
passing the lysate through a 21G needle 15 times. Samples were centrifuged and the supernatants were transferred to new tubes. RNA was then purified according to the kit instructions,
and eluted with nuclease-free water. Final RNA concentration was determined using a NanoDrop One spectrophotometer. Reverse transcription was performed using the TaqMan
Reverse Transcription Reagent kit (ABI, N8080234) in accordance with the manufacturer’s
instructions, also adding 2.5 μM random hexamers and oligo d(T)16 per reaction (ABI,
N8080127 and N8080128). The resulting cDNA was diluted in water and used for quantitative
PCR, which was performed with an ABI StepOnePlus machine using SYBR Green as a fluorophore. Each sample was run in triplicate reactions Primers used to amplify cDNA were as
follows in forward (F) and reverse (R) format, each used at a concentration of 0.5 μM per reaction. GAPDH: F, 5’-AATTCAACGGCACAGTCAAGGC-3’ and R, 5’-TACTCAGCACCGGCC
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Fig 1. Increased binding of ΔFosB to gene regions in APP versus NTG mice corresponds with a functional shift in ΔFosB gene targets. A,
Genomic distribution of ΔFosB binding peaks in NTG and APP mice. B, Number of genes targeted by ΔFosB in NTG and APP mice. C, Biological
Process GO terms enriched by the 52 ΔFosB gene targets shared between NTG and APP mice. D, Biological Process GO terms enriched by all genes
targeted by ΔFosB in NTG and APP mice. Dotted lines indicate p = 0.05 (two-sided hypergeometric tests with Benjamini-Hochberg correction). E,
Schematic depicting the number of genes in the EpilepsyGene database that are also ΔFosB targets in NTG mice, APP mice, or both.  p = 0.039 using
hypergeometric test for overlap between genes in the EpilepsyGene database and the list of ΔFosB target genes in APP mice.
https://doi.org/10.1371/journal.pone.0192508.g001

TCACC-3’; Asef2/Spata13: F, 5’-CTCAGAAGGCAGGACATG-3’ and R, 5’-CTCAGCCAAG
GCAAAGAC-3’; Gpc3: F, 50 -GACTTGAAAGTGGAGACTGC-30 and R, 50 -CCACATCCAGATC
ATAGGC-30 ; Magi1: F, 50 -ACCACCAAACCAAAGCAG-30 and R, 50 -AAGCGCAGAACATAAAG
ATC-30 ; Ano2 (GenBank: KC164761.2): F, 50 -GAGAGGAGCCTAGAAATCG-30 and R, 50 -TG
GTTGTCGTGAAAGTGC-30 .
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RNA-sequencing (RNA-seq)
Approximately 300 ng of RNA extracted from the dentate gyrus of APP mice with high ΔFosB
expression and from wild-type NTG mice (4 per genotype; 3 male and 1 female each) were
submitted to the University of Pennsylvania Next-Generation Sequencing Core, where library
preparation and Illumina hiSeq 2500 sequencing (paired-end reads, 100-bp read depth) was
performed. Raw mRNA reads were mapped to the mouse genome mm9. RNA-seq data were
fit to a Gaussian distribution via quantile normalization and log2 transformation, and p-values
for fold changes were corrected via false discovery rate (FDR). RNA-seq data were sexcompensated.

Immunohistochemistry (IHC)
Tissue preparation and IHC were performed as previously described [15, 16]. Briefly, fixed
brains were cryoprotected in 30% sucrose prior to sectioning at 30 μm thickness, and sections
were stored in cryoprotectant (30% glycerol, 30% ethylene-glycol in PBS) until processing. Ten
subseries were collected throughout the rostral-caudal extent of the brain. For staining with
3,3’-diaminobenzidine (DAB, Sigma), the antibodies used were rabbit anti-ΔFosB (Cell Signaling) and biotinylated goat anti-rabbit secondary (Vector). Further amplification was accomplished using Avidin-Biotin Complex (Vectastain) application. ΔFosB-IR quantification was
performed by assessing the mean pixel intensity using ImageJ software by a genotype-blinded
observer.

Statistics
General statistical analyses were performed using SPSS-23 (IBM), Prism 7 (GraphPad), and R
[24]. Sample sizes for both biochemical and behavioral experiments were determined based on
calculations performed on accumulated empirical data and power analyses. The number of
animals used for each experiment was appropriate to detect biochemical or behavioral differences. Unless otherwise stated, results are represented as sample means ± standard errors of
the mean. These data are distributed normally as stipulated by the central limit theorem. Differences between experimental groups were assessed by unpaired, two-tailed Student’s t test
when comparing means between two groups. Correlations were assessed by simple regression
analysis. No specific method of randomization was used, but animals were semi-randomly
assigned to experimental groups based on birth order after balancing for age, sex, and genotype. Hypergeometric analyses were performed to test the statistical significance of the overlap
between two lists of genes using R.

Results
Increased binding of ΔFosB to gene regions in APP versus NTG mice
High-throughput sequencing and genomic mapping of ΔFosB-bound DNA identified 2,343
significant binding peaks for ΔFosB in the hippocampus of NTG and APP mice. Subsequent
gene association analysis with Hypergeometric Optimization of Motif EnRichment (HOMER)
[25] found 1,197 total genes that were putative hippocampal ΔFosB targets in NTG and/or
APP mice. Notably, we detected a substantial shift in genomic regions containing ΔFosB binding peaks between NTG and APP mice (Fig 1A). A large proportion of ΔFosB binding peaks in
NTG mice occurred in intergenic regions (58.81%) and introns (35.59%), which may be
related to the high number of accessible chromatin sites in these genomic regions [26]. However, in APP mice we observed a redistribution of ΔFosB binding peaks, as peaks shifted away
from intergenic regions (decreased from 58.81% in NTG mice to 38.09% in APP mice) to bind
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various regions associated with genes. Regions that exhibited enrichment of ΔFosB binding
peaks in APP versus NTG mice included gene promoter, 5’ UTR, exon, intron, 3’ UTR regions.
Consistent with the increased binding of ΔFosB to gene-associated regions in APP mice, we
found that the number of total ΔFosB gene targets increased from 524 in NTG mice to 725 in
APP mice (Fig 1B).

ΔFosB gene targets function in distinct biological pathways in NTG and
APP mice
Interestingly, we found that out of the 1197 total putative hippocampal ΔFosB gene targets,
only 52 genes (~4%) were shared by NTG and APP mice (Fig 1B and S1 Table); the vast majority of targets appeared to be unique either to NTG (472 genes, 39.4%) or APP mice (673 genes,
56.2%). Given the low number of genes similarly bound by ΔFosB in NTG and APP mice, we
hypothesized that ΔFosB may perform disparate functions in NTG and APP mice by differentially regulating genes belonging to distinct molecular/cellular pathways. Therefore, to characterize the kinds of genes targeted by ΔFosB under physiologic and pathologic conditions, we
used Cytoscape [22] in combination with the plug-in ClueGO [23] to perform a GO analysis
of ΔFosB gene targets. This analysis categorizes gene targets by biological function and groups
genes that operate within the same molecular/cellular pathway. Each gene group is associated
with a GO term that describes the biological function performed by genes of that group, and a
p-value that indicates the significance of this particular GO term enrichment.
We first assessed GO terms for the 52 ΔFosB gene targets shared by NTG and APP mice.
The GO terms significantly enriched by these shared genes corresponded with fundamental
Table 1. ΔFosB targets in APP mice that are included in the EpilepsyGene database.
Gene

Gene name

abcc8

ATP binding cassette subfamily C member 8

ank3

Ankyrin-3; Ankyrin-G

braf

B-Raf transforming gene

chd2

Chromodomain helicase DNA-binding protein 2

cntn5

Contactin 5

cntnap2

Contactin-associated protein-like 2

gpr98

Adhesion G protein-coupled receptor V1

heg1

Heart development protein with EGF-like domains

kcnd2

Potassium voltage-gated channel, Shal-related family member 2; Kv4.2

kcnh5

Potassium voltage-gated channel subfamily H member 5; Eag2

lama2

Laminin subunit alpha 2

mef2c

Myocyte enhancer factor 2C

n6amt1

N-6 adenine-specific DNA methyltransferase 1

nedd4l

Neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase

oprm1

Opioid receptor mu 1

pacs2

Phosphofurin acidic cluster sorting protein 1

pcdh19

Protocadherin 19

pign

Phosphatidylinositol glycan anchor biosynthesis class N protein

ptprr

Protein tyrosine phosphatase, receptor type R

scn9a

Sodium channel voltage-gated type IX, alpha; Nav1.7

slc35a3

Solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member 3

ss18l1

SS18; nBAF chromatin remodeling complex subunit like 1

wnk1

WNK lysine deficient protein kinase 1

https://doi.org/10.1371/journal.pone.0192508.t001
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cellular processes, such as organelle localization, cell development, differentiation, and cell-cell
adhesion (Fig 1C). We then evaluated major GO terms belonging to all 1197 genes targeted by
ΔFosB in NTG and APP mice (Fig 1D). We found that despite the fact that ΔFosB largely targeted different genes in NTG and APP mice, there was significant enrichment of GO terms for
neuron development, dendrite development, and neurogenesis in both types of mice. However, we also found that these three GO terms were consistently less enriched in APP mice
than in NTG mice, suggesting that ΔFosB in APP mice also targeted many genes that do not
function in these domains. Further analysis of major GO terms in APP mice revealed that
ΔFosB targeted a significant number of genes involved in ion transmembrane transport, glutamate receptor signaling, and regulation of membrane potential. Notably, those GO terms were
not significantly enriched in NTG mice. In contrast, GO terms related to Wnt signaling, synapse maturation, and cellular component assembly were significantly enriched in NTG mice,
but not APP mice.
The diversification of GO terms in APP mice to include ion transport, glutamate receptor
signaling, and regulation of membrane potential was striking given the recurrent seizures
exhibited by both AD patients and mouse models, as well as the critical role that seizures play
in cognitive deficits [15, 16, 27–29]. We therefore assessed whether ΔFosB gene targets in APP
mice are involved in epilepsy-related pathways by comparing our list of gene targets to EpilepsyGene, a database cataloging 499 genes and 3931 gene variants that have been implicated in
clinical epilepsy [30]. Hypergeometric enrichment analyses revealed that genes bound by
ΔFosB in APP mice were significantly overrepresented in the EpilepsyGene list (p = 0.039),
whereas genes bound by ΔFosB in NTG mice were not (p = 0.52) (Fig 1E). Table 1 lists the
ΔFosB target genes in APP mice that are also represented in the EpilepsyGene database. Notably, only 1 gene (braf) in Table 1 was bound by ΔFosB in both APP and NTG mice; all others
were uniquely bound in APP mice.

GO network analysis reveals expanded and diversified repertoire of ΔFosB
targets in APP mice
To gain more comprehensive insight into the repertoire of genes targeted by ΔFosB in NTG
and APP mice, we performed a nodal network analysis of GO terms enriched by ΔFosB gene
targets in these mice (Fig 2). Since many genes are known to perform multiple cellular functions, different gene groups can contain similar genes. By connecting ΔFosB-enriched gene
groups via shared genes, coordinated gene networks that are simultaneously targeted by
ΔFosB in NTG and APP mice can be assessed. This network-level analysis of ΔFosB gene targets provides a comprehensive view of distinct cellular programs engaged by ΔFosB under
physiologic and pathologic conditions. Consistent with our assessment of individual GO
terms in Fig 1D, nodal network analysis of enriched GO clusters in NTG mice reveal an extensively interconnected cluster containing GO terms neuron development, dendrite development, neurogenesis, and synapse maturation, as well as a Wnt signaling pathway network
involving the regulation of cell polarity (Fig 2A). Overall, the GO network of NTG mice highlights involvement of ΔFosB in pathways critical for neurodevelopment and maintenance of
the neural network architecture.
By comparison, the GO network of APP mice shows an expanded and diversified array of
GO terms, consistent with the expanded and diversified array of ΔFosB gene targets in APP
mice (Fig 2B). Unlike the nodal network diagram of NTG mice, the APP diagram displays
numerous clusters containing GO terms enriched with genes related to neuronal excitability,
glutamatergic neurotransmission, and action potential regulation. Notable GO terms and clusters in APP mice that did not appear in NTG mice contain genes for 1) ion channels, ion
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transporters, and channel-localizing scaffolding proteins, and 2) genes linked to calcium
homeostasis. Although GO clusters relating to neurodevelopmental processes are represented
in APP mice, these clusters contain fewer GO terms and are less interconnected than their
NTG counterparts. These results demonstrate a functional shift of ΔFosB gene targets away
from neurodevelopmental processes and towards regulation of excitability in APP mice.

Binding of ΔFosB to putative targets corresponds to changes in gene
transcription
Given the crucial role of ΔFosB in epigenetic gene regulation [31], differential binding of
ΔFosB to gene targets in APP and in NTG mice genotypes is likely to have a major effect on
neuronal gene expression. Therefore, to evaluate whether alterations in the binding of ΔFosB
to various gene targets correspond with downstream changes in transcription, we analyzed the
mRNA expression of four representative ΔFosB gene targets that demonstrated differential
ΔFosB binding in NTG versus APP mice. These genes were selected from major representative
GO clusters in NTG and APP mice.
We first analyzed mRNA expression of Asef2 (also known as Spata13) and Gpc3, two genes
that ChIP-seq binding peak analysis indicated were significantly bound by ΔFosB in NTG
mice, but not APP mice (Fig 3A and 3D). These genes belong to the neurodevelopmental GO
cluster (2A, red/blue) of NTG mice. Asef2 encodes a guanine nucleotide exchange factor that
regulates the actin cytoskeleton [32, 33] and facilitates dendritic spine and synapse formation
[34]. Gpc3 encodes glypican 3, a heparan sulfate proteoglycan (HSPG) implicated in hippocampal patterning and excitatory synapse development [35–37]. Using unbiased RNA-seq and
qPCR analyses, we found that differential binding of ΔFosB to these genes in NTG and APP
mice was indeed associated with downstream changes in mRNA expression. Our data showed
that mRNA levels of both Asef2 (Fig 3B and 3C) and Gpc3 (Fig 3E and 3F) were decreased in
APP versus NTG mice, coinciding with decreased ΔFosB binding to these genes.
We also analyzed the mRNA expression of Magi1 and Ano2, genes that were significantly
bound by ΔFosB in APP mice, but not NTG mice (Fig 3G and 3J). These genes were selected
from the APP GO cluster containing ion transmembrane transport and regulation of membrane potential. Magi1 encodes a scaffolding protein that regulates the calcium-activated big
potassium (BK) channel [38, 39]. Ano2 encodes anoctamin 2, a somatodendritic calcium-activated chloride channel [40–42]. Differential binding of ΔFosB to Magi1 and Ano2 was also
associated with changes in mRNA expression, as increased binding of ΔFosB to these genes in
APP mice corresponded with decreased mRNA expression of both Magi1 (Fig 3H and 3I) and
Ano2 (Fig 3K and 3L).
Of the four example genes described here, ΔFosB bound to an intergenic region upstream
of Asef2, and to intronic regions of Gpc3, Magi1 and Ano2 (see Fig 3). We also assessed the distribution of genomic regions bound by ΔFosB for other genes that exhibited differential
expression in RNA-seq (S1 Fig), and examined whether binding was associated with increased
or decreased gene expression. All ΔFosB target genes that were differentially regulated in
RNA-seq were bound in either promoter, intergenic, or intronic regions. Notably, gene
expression could be increased or decreased in association with binding of ΔFosB to any of
these genomic regions. This finding suggests that the type of genomic region bound by ΔFosB
is unlikely to be a determinant of the direction of gene expression modulation.

Discussion
We have generated a comprehensive ChIP-seq profile of ΔFosB gene targets in the hippocampus of both NTG and APP mice. The characterization of ΔFosB gene targets via GO analysis
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Fig 3. Differential binding of ΔFosB to target genes in NTG and APP mice corresponds with changes in downstream mRNA
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ChIP-seq binding peaks are marked on gene tracks by red boxes, with respective insets displaying magnified peaks (arrows). B,C,
Asef2 (Spata13) mRNA expression in NTG and APP mice, quantified via RNA-seq ( p = 1.3x10-9) and qPCR ( p = 1.7x10-4). E,
F, Gpc3 mRNA expression in NTG and APP mice, quantified via RNA-seq ( p = 1.2x10-4) and qPCR ( p = 0.035). H,I, Magi1
mRNA expression in NTG and APP mice, quantified via RNA-seq ( p = 0.02) and qPCR ( p = 2x10-4). K,L, Ano2 mRNA
expression in NTG and APP mice, quantified via RNA-seq ( p = 0.028) and qPCR ( p = 1x10-3). For RNA seq n = 4 per genotype,
for qPCR n = 13–17 per genotype. Differences between genotypes were assessed using Benjamini-Hochberg FDR for RNA-seq data,
and unpaired Student’s t-test for qPCR data. QN, quantile normalization.
https://doi.org/10.1371/journal.pone.0192508.g003

also highlight two apparently distinct programs of hippocampal gene regulation under physiologic and AD-associated pathologic conditions. We found that in the normal hippocampus of
NTG mice, ΔFosB targeted many genes involved in neuronal development and cell morphogenesis, implicating its role in the formation and maintenance of neural circuitry. The putative
role of ΔFosB in dendrite and synapse development is particularly interesting considering that
hippocampal expression of activity-dependent ΔFosB is sparse under normal circumstances
[10, 13–16]. We thus hypothesize that expression of ΔFosB under physiologic conditions may
serve to modulate synaptic plasticity in a small population of highly active hippocampal neurons, perhaps as a homeostatic mechanism. Consistent with our findings, a recent study found
that spatial learning and novel environment exposure induces hippocampal expression of
ΔFosB, which plays a crucial role in regulating dendritic spine morphology [19]. Furthermore,
homeostatic control of neuronal plasticity is a known function of many other IEG proteins
[1, 43, 44].
However, in the pathologic hippocampus of APP mice, we found that the repertoire of
ΔFosB gene targets expanded and diversified to include genes involved in the regulation of
membrane potential and neuronal excitability. This finding suggests a functional shift in
ΔFosB gene targets that occurs with seizure-induced ΔFosB accumulation. This functional
shift is significant considering the aberrant hyperexcitability of the APP hippocampus [45–47].
Since robustly increased expression of ΔFosB in the APP hippocampus is a direct result of neuronal hyperactivity [16], the putative shift in ΔFosB function towards regulation of neuronal
excitability may in turn represent a compensatory neuroprotective response to limit excitotoxicity. Consistent with this view, a recent study found that ΔFosB could protect neurons
from ischemic injury [48]. We have also shown in previous studies that ΔFosB impairs hippocampal function and cognition [15, 16], likely by reducing synaptic plasticity and neuronal
response to stimulation. Together, these findings suggest that ΔFosB regulates a critical balance
between neuronal function and neuroprotection in the hyperexcitable hippocampal network
of APP mice.
We also assessed how changes in the binding of ΔFosB to various targets in NTG and APP
mice could impact downstream transcription. Via RNA-seq and qPCR analyses, we showed
that genes exhibiting both increased and decreased ΔFosB binding in APP mice also demonstrated alterations in mRNA expression. Interestingly, the four ΔFosB gene targets we investigated all had decreased mRNA expression in APP relative to NTG mice, despite opposite
trends in ΔFosB gene binding. Asef2 and Gpc3 had high ΔFosB binding in NTG mice, whereas
Magi1 and Ano2 had high ΔFosB binding in APP mice. Together, these results suggest that
ΔFosB promotes transcription of Asef2 and Gpc3 in NTG mice, and suppresses Magi1 and
Ano2 transcription in APP mice. These results are consistent with previous studies showing
that ΔFosB has the ability to bidirectionally alter gene expression [4]. Decreased mRNA
expression of Magi1 in APP mice is also notable considering that Magi1 sequesters BK channels from cell surfaces [39]. Reduction of Magi1 protein in the APP hippocampus would allow
increased surface expression of BK channels, which in turn could increase potassium conductance and reduce neuronal excitability. In addition, ΔFosB-mediated suppression of Ano2
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transcription in the hippocampus could also reduce neuronal excitability since Ano2 affects
membrane repolarization, and mice in which Ano2 has been ablated exhibit decreased excitability of inferior olive neurons [40–42]. Therefore, validation of ΔFosB-mediated suppression
of Magi1 or Ano2 could provide further support for a neuroprotective role of ΔFosB in APP
mice.
Seizure-induced accumulation of ΔFosB likely contributes to the expansion and functional
diversification of ΔFosB gene targets in APP mice. However, differences in the chromatin
accessibility landscape of APP versus NTG neurons may also have a major impact on how
ΔFosB interacts with the genome. Recent studies found that neuronal activity or behavioral
training cause significant chromatin reorganization in hippocampal neurons [26, 49]. Activity
appears to largely induce chromatin relaxation at gene regions throughout the genome, allowing various IEG transcription factors such as cFos and FosB to access gene targets [26]. Considering that ΔFosB is closely related to FosB, these activity-induced changes in chromatin
structure likely affect accessibility of gene targets to ΔFosB as well, and may contribute to the
increased number and diversity of genes bound by ΔFosB in APP versus NTG mice. Indeed,
neuronal hyperexcitability in the APP hippocampus may chronically alter chromatin structure
in a way that allows ΔFosB to bind genes that are normally inaccessible under physiologic conditions. Consistent with this view, the binding peak distribution of ΔFosB in APP mice aligns
closely with genomic regions found to exhibit chromatin relaxation after neuronal activation
[26]. In conclusion, our findings have provided critical insight into the diverse functions of
ΔFosB in the hippocampus under both physiologic and pathologic conditions. Future characterization of how ΔFosB influences hippocampal gene regulation may aid the discovery of
novel therapeutic targets to improve cognition and neuroprotection in AD and other seizurerelated disorders.

Supporting information
S1 Fig. Binding of ΔFosB to specific genomic regions is associated with both increased and
decreased gene expression. Genes bound by ΔFosB in ChIP-seq that showed differential
expression at the p = 0.1 level by RNA-seq were subdivided by the genomic regions at which
they were bound. Numbers within bars denote the percentage of genes that were increased or
decreased for each region and genotype.
(EPS)
S1 Table. ΔFosB gene targets in APP mice, NTG mice, or both. ΔFosB ChIP-seq enrichment
data were analyzed, as described in the Methods, to generate lists of genes putatively bound by
ΔFosB in either APP mice, NTG mice, or in both genotypes. Lists of genes for each genotype,
or shared between the genotypes, can be found on individual tabs within the file.
(XLSX)
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